Intuitive Surgical, Inc. $ISRG Shares Purchased by DDD Partners LLC

DDD Partners LLC raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 746.8% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,504 shares of the medical equipment provider’s stock after buying an additional 4,854 shares during the quarter. DDD Partners LLC’s holdings in Intuitive Surgical were worth $2,462,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of ISRG. Tobam increased its position in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $27,000. Greykasell Wealth Strategies Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $27,000. Princeton Global Asset Management LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $30,000. Finally, Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical in the third quarter valued at approximately $37,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms have commented on ISRG. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research note on Wednesday, October 22nd. BTIG Research reaffirmed a “buy” rating and issued a $616.00 price objective on shares of Intuitive Surgical in a research report on Friday, January 23rd. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a research report on Tuesday, January 27th. Piper Sandler reissued an “overweight” rating and issued a $620.00 price target (up from $610.00) on shares of Intuitive Surgical in a research note on Friday, January 23rd. Finally, Raymond James Financial upped their price objective on shares of Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research note on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $617.23.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 4,500 shares of the company’s stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $547.36, for a total value of $2,463,120.00. Following the completion of the sale, the senior vice president owned 907 shares of the company’s stock, valued at $496,455.52. This represents a 83.23% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Fredrik Widman sold 133 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the sale, the vice president owned 660 shares in the company, valued at approximately $326,673.60. The trade was a 16.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 56,189 shares of company stock worth $30,785,441. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $485.84 on Friday. The company has a market cap of $172.54 billion, a price-to-earnings ratio of 61.58, a price-to-earnings-growth ratio of 3.71 and a beta of 1.65. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $609.08. The stock’s 50-day moving average is $541.62 and its 200-day moving average is $510.24.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company’s revenue was up 18.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.21 EPS. Research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.